Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-07-19 | Redeye | Redeye: Enzymatica Q2 2023 - Waiting for the cold season | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Penser Access | Penser Access: Kommande studieresultat i fokus - Enzymatica | Pressreleaser | Visa Stäng |
|
||||
2023-07-18 | Enzymatica | Enzymatica AB: Kvartalsrapport Q2/2023: En spännande och viktig tid framöver | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Enzymatica | Enzymatica AB: Interim report Q2/2023: An exciting and important time ahead | Rapporter | Ladda ner | Visa Stäng |
Rapporter |
Enzymatica AB: Interim report Q2/2023: An exciting and important time aheadQ2 H1
million. million.
-11.2 (-15.9) million. -25.5 (-34.0) million.
diluted, were SEK -0.07 (-0.10). diluted, were SEK -0.16 (-0.22).
activities totaled SEK -9.5 (-21.5) activities totaled SEK -21.7 (-31.7) Significant events during the Significant events after the quarter
were reported during the the end of the quarter.
UK, conducted a clinical
Innsbruck, Austria, conducted ”The first half of 2023 showed 58% growth compared to the same period last year. The second quarter is always the weakest of the year for us, as it is the period when the number of colds is the lowest. Still, the second quarter was an intense period. Discussions on launches in some of the world’s largest cold markets intensified and our research program continued. In August, we expect the results from two important scientific studies”, said Claus Egstrand, CEO of Enzymatica. The full report is available on: www.enzymatica.com/investors/financial-reports This information is information that Enzymatica is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CET on July 18, 2023. For more information, please contact: Claus Egstrand, Chief Executive Officer, Enzymatica AB Stefan Olsson, Communication Manager, Enzymatica AB Enzymatica AB is headquartered in Lund, Sweden, and is listed on Nasdaq First North Growth Market. |
||||
2023-05-16 | Penser Access | Penser Access: Interview with Enzymatica - Erik Penser Bank - May 16th 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-05-04 | Enzymatica | Bulletin from Annual General Meeting of Enzymatica AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | Enzymatica | Kommuniké från årsstämma i Enzymatica AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-28 | Penser Access | Penser Access: Upp till bevis - Enzymatica | Pressreleaser | Visa Stäng |
|
||||
2023-04-28 | Redeye | Redeye: Enzymatica Q1 2023 - A step in the right direction | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | Enzymatica | Enzymatica AB: Kvartalsrapport Q1/2023: Stark start på året - Enzymaticas tillväxtresa fortsätter enligt plan | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-27 | Enzymatica | Enzymatica AB: Interim report Q1/2023: Strong start to the year - Enzymatica's growth journey continues according to plan | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-05 | Enzymatica | Enzymatica AB: Enzymatica publishes annual report for 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-05 | Enzymatica | Enzymatica AB: Enzymatica publicerar årsredovisning för 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-03-31 | Enzymatica | Notice of Annual General Meeting 2023 in Enzymatica AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-31 | Enzymatica | Kallelse till årsstämma 2023 i Enzymatica AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-20 | Penser Access | Penser Access: Vår syn på bolagets potential är intakt - Enzymatica | Pressreleaser | Visa Stäng |
|
||||
2023-02-20 | Redeye | Redeye: Enzymatica Q4 2022 - Lower than our estimates | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-17 | Enzymatica | Enzymatica AB: Interim report Q4/2022: A year that laid the foundation for growth | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-17 | Enzymatica | Enzymatica AB: Kvartalsrapport Q4/2022: Ett år som lade grunden för tillväxt | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-12-06 | Redeye | Redeye: Redeye Initiates Coverage of Enzymatica | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-16 | Enzymatica | Enzymatica AB: Enzymatica and University of Kent launch study to explore prevention of upper respiratory virus infections in elite athletes | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-16 | Enzymatica | Enzymatica AB: Enzymatica och University of Kent startar studie för att undersöka hur elitidrottare kan förebygga virusinfektioner i de övre luftvägarna | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-03 | Penser Access | Penser Access: Inte helt ute ur coronatunneln - Enzymatica | Analyser | Visa Stäng |
|
||||
2022-11-02 | Enzymatica | Enzymatica AB: Kvartalsrapport Q3/2022: En bredare roll för ColdZyme adderar potential för framtiden | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-02 | Enzymatica | Enzymatica AB: Interim report Q3/2022: A broader role for ColdZyme adds potential for the future | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-01 | Enzymatica | Enzymatica AB: New study confirms ColdZyme stops viruses causing Covid-19 from adhering to human respiratory cells | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-01 | Enzymatica | Enzymatica AB: Ny studie bekräftar: ColdZyme hindrar virus som orsakar Covid-19 från att fästa vid mänskliga luftvägsceller | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | Enzymatica | Enzymatica AB: Enzymatica announces outcome of new rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | Enzymatica | Enzymatica AB: Enzymatica offentliggör utfall i företrädesemissionen | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-18 | Enzymatica | Enzymatica AB: Enzymatica publishes supplementary prospectus | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-18 | Enzymatica | Enzymatica AB: Enzymatica offentliggör tilläggsprospekt | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-16 | Enzymatica | Enzymatica AB: ColdZyme blockerar även omikronvarianterna BA.4 och BA.5 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-16 | Enzymatica | Enzymatica AB: ColdZyme also blocks omicron variants BA.4 and BA.5 | Pressreleaser | Ladda ner | Visa Stäng |
|